Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)

3.21
Delayed Data
As of Jul 29
 -0.09 / -2.73%
Today’s Change
2.69
Today|||52-Week Range
15.93
-72.96%
Year-to-Date
No recent news for Dicerna Pharmaceuticals Inc.

Today’s Trading

Previous close3.30
Today’s open3.29
Day’s range3.15 - 3.34
Volume104,627
Average volume (3 months)210,569
Market cap$68.6M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-3.00%
Earnings growth (this year)-5.05%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales1,310.90
Price/Book0.75

Competitors

 Today’s
change
Today’s
% change
CAPRCapricor Therapeutic...-0.03-0.80%
SBPHSpring Bank Pharmace...+0.84+9.31%
MSTXMast Therapeutics In...-0.01-1.62%
XOMAXOMA Corp+0.09+15.65%
Data as of 4:01pm ET, 07/29/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$184.0K
Annual profit (last year)-$62.8M
Net profit margin-34,151.63%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas M. Fambrough
Chief Financial Officer
John B. Green
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs